Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Genetic variation

Revolutionary Gene-Editing Tool HACE Offers Unprecedented Precision in Genetic Research

A groundbreaking gene-editing tool, Helicase-Assisted Continuous Editing (HACE), offers scientists unparalleled precision in targeting genetic mutations. By combining helicase enzymes with CRISPR technology, HACE enables the introduction of specific mutations without disrupting the entire genome, revolutionizing research in gene function and disease mechanisms. Recent studies demonstrate HACE’s potential in identifying drug resistance mutations in cancer, paving the way for novel therapies and enhanced cancer treatment strategies.

Mayo Clinic Study Reveals Genetic Cancer Risks in 550 Patients

Mayo Clinic study reveals genetic cancer risks in 550 patients, with many carriers of hereditary mutations unaware of their risk. Lead author stresses the importance of early detection for proactive screenings and targeted therapies. Disparities in genetic screening guidelines for underrepresented minorities also highlighted.

Genomic Data in the All of Us Research Program

The All of Us Research Program is making significant strides in mapping the genetic basis of human disease, with a focus on diversity and inclusion. The latest release includes 245,388 clinical-grade genome sequences, with a high percentage of participants from historically under-represented communities and racial and ethnic minorities. The comprehensive dataset has identified over 1 billion genetic variants, with coding consequences for over 3.9 million, and is publicly available for researchers to access. This diverse dataset is expected to advance the promise of genomic medicine for all.

Born in Guangzhou Cohort Study: Significant Genetic Discoveries Impact Understanding of Genetics and Environment on Human Health

The Born in Guangzhou Cohort Study has led to significant genetic discoveries that could impact the understanding of genetics and environment on human health. The study, which focuses on large-scale, prospective birth cohorts, is a crucial strategy for understanding the…

New Method Proposed to Improve Discovery of Risk Genes for Complex Traits

A new study published in Nature Genetics has proposed a method to improve the discovery of risk genes for complex traits by adjusting for genetic confounders in transcriptome-wide association studies (TWAS). Researchers have long been using expression quantitative trait loci…

University of Eastern Finland Study Reveals Impact of Genetic Variation on Gene Expression and Chromatin Accessibility

In a recent groundbreaking study, the University of Eastern Finland has uncovered the profound impact of genetic variation on gene expression and chromatin accessibility. Published on January 22, 2024, this study delves into the intricate realm of genetic variations, chromatin…

Comprehensive Analysis Confirms Five Key Parkinson’s Disease Variants

A recent study published in Npj Parkinson’s Disease has conducted a comprehensive analysis of rare Parkinson’s disease (PD) variants in a large-scale cohort, confirming the existence of five key PD variants. This landmark study sheds light on the genetic factors…

Contingency, repeatability, and predictability in the evolution of a prokaryotic pangenome

Contingency, repeatability, and predictability in the evolution of a prokaryotic pangenome By Alan Beavan, Maria Rosa Domingo-Sananes, and James O. McInerney The evolution of prokaryotic pangenomes continues to intrigue scientists as they uncover the remarkable variability within these species. A…